Use Code ONLINE20 to Save 20% On Global Market Reports – Gain Access to Trusted Market Data, Growth Indicators, and Industry Analytics
What Are the Key Growth Indicators and Market Expansion Estimates for the Monkey Pox Treatment Market Through 2029?
The monkey pox treatment market size has grown rapidly in recent years. It will grow from $0.09 billion in 2024 to $0.1 billion in 2025 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period can be attributed to outbreaks in endemic regions, zoonotic transmission awareness, smallpox eradication legacy, public health initiatives, emergence of human cases.
The monkey pox treatment market size is expected to see rapid growth in the next few years. It will grow to " $0.16 billion in 2029 at a compound annual growth rate (CAGR) of 13.0%. The growth in the forecast period can be attributed to globalization and travel, government funding and support, biotech and pharmaceutical investment, public health surveillance, and regulatory approvals. Major trends in the forecast period include antiviral drug development, use of smallpox vaccines, monoclonal antibodies, combination therapies, and long-term immunity research.
Get your free report sample today:
Which Key Drivers Are Fueling Growth in the Monkey Pox Treatment Market?
The increasing prevalence of zoonotic infection is expected to propel the growth of the monkeypox treatment market going forward. A zoonotic infection is a disease that is transmitted from animals to humans through direct contact with contaminated environments or vectors. With increased human-animal interaction by bringing people and animals into closer contact raises zoonotic infection risks. Moreover, climate change worsens this risk by expanding disease vector ranges and introducing pathogens to new areas. Monkeypox treatments are used to manage zoonotic mpox by targeting the virus and alleviating symptoms in both humans and potentially infected animals. For instance, in August 2024, according to a report published by the UK Health Security Agency, a UK-based government agency, there were 3,732 confirmed mpox cases in the UK, rising by 21 more in 2023 with 3753 cases. Therefore, the increasing prevalence of zoonotic infection drives the monkeypox treatment market.
How Is the Monkey Pox Treatment Market Categorized Based on Key Segments?
The monkey pox treatmentmarket covered in this report is segmented –
1) By Treatment Type: Prophylactic Vaccines; Therapeutics
2) By Dosage Forms: Solid; Liquid; Semi Solid
3) By Route Of Administration: Oral; Topical; Parenteral
4) By Distribution Channel: Retail Pharmacies; Hospital Pharmacies; Online Pharmacies
Subsegments:
1) By Prophylactic Vaccines: Vaccinia-Based Vaccines; Modified Vaccinia Ankara (MVA) Vaccines; Other Vaccines (Recombinant Vaccines)
2) By Therapeutics: Antiviral Agents (Tecovirimat, Brincidofovir); Immune Modulators; Supportive Care Treatments
Which Future-Ready Trends Are Expected to Influence the Monkey Pox Treatment Market?
Major companies operating in the monkeypox treatment market focus on remote monitoring and teletherapy solutions such as virtual care to enhance accessibility, streamline patient management, and improve overall treatment outcomes. Virtual care for monkeypox treatment provides remote medical consultations, symptom evaluation, and management strategies to individuals at risk or infected, facilitating access to care while reducing the need for in-person visits. For instance, in August 2022, Folx Health, a US-based healthcare company, introduced Monkeypox Care, virtual primary care services for individuals at risk of or affected by monkeypox. It employs a comprehensive strategy that includes education, counseling, symptom evaluation, and referrals. The initiative is designed to reach individuals in care deserts—areas with limited access to healthcare, ensuring that quality information and referrals are accessible to all, regardless of location.
Who Are the Leading Market Participants in the Monkey Pox Treatment Market?
Major companies operating in the monkey pox treatment market are Roche Holding AG, Merck & Co. Inc., Sanofi S.A., Gilead Sciences Inc., BioNTech SE, Moderna Inc., Quest Diagnostics Incorporated, Novavax Inc., Laboratory Corporation of America Holdings, Emergent BioSolutions Inc., Bavarian Nordic A/S, Aegis Sciences Corporation, Daan Gene Co. Ltd., Sansure Biotech Inc., SIGA Technologies Inc., Elabscience Biotechnology Inc., Mayo Clinic Laboratories, Tonix Pharmaceuticals Holding Corp., Altona Diagnostics GmbH, Lansion Biotechnology Co. Ltd., Goldsite Diagnostics Inc., Chimerix Inc., Emcure Pharmaceuticals Ltd., VBI Vaccines Inc
Get the detailed monkey pox treatment market report today
Which Regions Are Driving the Highest Demand in the Monkey Pox Treatment Market?
North America was the largest region in the monkey pox treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the monkey pox treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: Market Research Reports
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment